Projected accrual, mean, and standard deviation for newly diagnosed (n = 17, 25.8%) and relapsed/refractory (n = 19, 28.8%) trials
| Type and location . | n (%) . | Mean . | SD . |
|---|---|---|---|
| Newly diagnosed | |||
| United States only | 824 (24) | 103 | 165.37 |
| International only | 1286 (38) | 214.33 | 225.71 |
| United States + international | 1322 (39) | 440.67 | 334.35 |
| Total, N | 3432 | ||
| Relapsed/refractory | |||
| United States only | 1025 (34) | 73.21 | 79.45 |
| International only | 1073 (36) | 214.60 | 150.11 |
| United States + international | 924 (31) | 308 | 74.71 |
| Total, N | 3022 |
| Type and location . | n (%) . | Mean . | SD . |
|---|---|---|---|
| Newly diagnosed | |||
| United States only | 824 (24) | 103 | 165.37 |
| International only | 1286 (38) | 214.33 | 225.71 |
| United States + international | 1322 (39) | 440.67 | 334.35 |
| Total, N | 3432 | ||
| Relapsed/refractory | |||
| United States only | 1025 (34) | 73.21 | 79.45 |
| International only | 1073 (36) | 214.60 | 150.11 |
| United States + international | 924 (31) | 308 | 74.71 |
| Total, N | 3022 |
SD, standard deviation.